A detailed history of Bck Capital Management LP transactions in Surmodics Inc stock. As of the latest transaction made, Bck Capital Management LP holds 17,000 shares of SRDX stock, worth $671,840. This represents 0.23% of its overall portfolio holdings.

Number of Shares
17,000
Previous 17,000 -0.0%
Holding current value
$671,840
Previous $714,000 7.7%
% of portfolio
0.23%
Previous 0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$25.39 - $42.1 $431,630 - $715,700
17,000 New
17,000 $714,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $553M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Bck Capital Management LP Portfolio

Follow Bck Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bck Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Bck Capital Management LP with notifications on news.